Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors

被引：0
|
作者：
Annemiek van Ommen-Nijhof
Judy N. Jacobse
Lars C. Steggink
Joop D. Lefrandt
Jourik A. Gietema
Flora E. van Leeuwen
Michael Schaapveld
Gabe S. Sonke
机构：
[1] The Netherlands Cancer Institute,Department of Medical Oncology
[2] Leiden University Medical Center,Department of Radiotherapy
[3] Erasmus University Medical Center,Department of Medical Oncology
[4] University Medical Center Groningen,Department of Internal Medicine
[5] University Medical Center Groningen,Department of Medical Oncology
[6] The Netherlands Cancer Institute,Department of Psychosocial Research and Epidemiology
[7] The Netherlands Cancer Institute,Department of Medical Oncology
[8] University of Amsterdam,Department of Medical Oncology
来源：
Breast Cancer Research and Treatment | 2022年 / 196卷
关键词：
Breast cancer; Endocrine therapy; Aromatase inhibitor; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：591 / 602
页数：11
相关论文
共 50 条
  • [1] Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors
    van Ommen-Nijhof, Annemiek
    Jacobse, Judy N.
    Steggink, Lars C.
    Lefrandt, Joop D.
    Gietema, Jourik A.
    van Leeuwen, Flora E.
    Schaapveld, Michael
    Sonke, Gabe S.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (03) : 591 - 602
  • [2] Is Adjuvant Aromatase Inhibitor Therapy expanded? Breast Cancer in the Early Stages
    不详
    GYNAKOLOGE, 2016, 49 (09): : 636 - 636
  • [3] Cardiovascular disease risk and statin use among women with breast cancer treated with adjuvant aromatase inhibitor therapy
    Chen, Monica F.
    Manger, Morgan
    Crew, Katherine D.
    CANCER RESEARCH, 2020, 80 (04)
  • [4] Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data
    Grana, G.
    JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (07) : 585 - 592
  • [5] The use of aromatase inhibitors in adjuvant therapy for early breast cancer
    Jonat, W
    Hilpert, F
    Maass, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (Suppl 1) : S32 - S38
  • [6] The use of aromatase inhibitors in adjuvant therapy for early breast cancer
    Walter Jonat
    Felix Hilpert
    Nicolai Maass
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 32 - 38
  • [7] Aromatase inhibitor therapy and hair loss among breast cancer survivors
    Gallicchio, Lisa
    Calhoun, Carla
    Helzlsouer, Kathy J.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (02) : 435 - 443
  • [8] Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
    Gnant, Michael
    Fitzal, Florian
    Rinnerthaler, Gabriel
    Steger, Guenther G.
    Greil-Ressler, Sigrun
    Balic, Marija
    Heck, Dietmar
    Jakesz, Raimund
    Thaler, Josef
    Egle, Daniel
    Manfreda, Diether
    Bjelic-Radisic, Vesna
    Wieder, Ursula
    Singer, Christian F.
    Melbinger-Zeinitzer, Elisabeth
    Haslbauer, Ferdinand
    Sevelda, Paul
    Trapl, Harald
    Wette, Viktor
    Wimmer, Kerstin
    Gampenrieder, Simon P.
    Bartsch, Rupert
    Kacerovsky-Strobl, Stephanie
    Suppan, Christoph
    Brunner, Christine
    Deutschmann, Christine
    Soelkner, Lidija
    Fesl, Christian
    Greil, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (05): : 395 - 405
  • [9] Aromatase inhibitor therapy and hair loss among breast cancer survivors
    Lisa Gallicchio
    Carla Calhoun
    Kathy J. Helzlsouer
    Breast Cancer Research and Treatment, 2013, 142 : 435 - 443
  • [10] Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?
    Moscetti, Luca
    Fabbri, Maria Agnese
    Sperduti, Isabella
    Fabrizio, Nelli
    Frittelli, Patrizia
    Massari, Annalisa
    Pompei, Luciano
    D'Auria, Giuliana
    Pofi, Enrico
    Ruggeri, Enzo Maria
    TUMORI, 2015, 101 (05) : 469 - 473
12345